Evaluation of in vivo and in vitro recovery rate of anatoxin-a through the microdialysis probe

Toxicon

Volumn 52, Issue 7, 2008, Pages 817-823

  Campos, F ^a,b   Rellan S ^a   Duran, R ^a   Gago, A ^a   Faro, L F ^a   Alfonso, M ^a  

^a UNIVERSITY OF VIGO   (Spain)

^b INST D INVESTIGACIONS B   (Spain)

Author keywords

Anatoxin a; Fluorescence detection; High performance liquid chromatography; In vitro recovery; In vivo recovery; Microdialysis

Indexed keywords

ANATOXIN A; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR SPACE; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MECHANICAL PROBE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 55249100205     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2008.08.019     Document Type: Article

References (30)

1. Alfonso M., Duran R., Campos F., Perez-Vences D., Faro L.R., and Arias B. Mechanisms underlying domoic acid-induced dopamine release from striatum: an in vivo microdialysis study. Neurochem. Res. 28 (2003) 1487-1493
2. Amar M., Thomas P., Johnson C., Lunt G.G., and Wonnacott S. Agonist pharmacology of the neuronal alpha 7 nicotinic receptor expressed in Xenopus oocytes. FEBS Lett. 327 (1993) 284-288
3. Anderson D.J., Puttfarcken P.S., Jacobs I., and Faltynek C. Assessment of nicotinic acetylcholine receptor-mediated release of [(3)H]-norepinephrine from rat brain slices using a new 96-well format assay. Neuropharmaogy 39 (2000) 2663-2672
4. Aronstam R.S., and Witkop B. Anatoxin-a interactions with cholinergic synaptic molecules. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 4639-4643
5. Campos F., Alfonso M., Vidal L., Faro L.R., and Duran R. Mediation of glutamatergic receptors and nitric oxide on striatal dopamine release evoked by anatoxin-a. An in vivo microdialysis study. Eur. J. Pharmacol. 548 (2006) 90-98
6. Campos F., Duran R., Vidal L., Faro L.R., and Alfonso M. In vivo effects of the anatoxin-a on striatal dopamine release. Neurochem. Res. 31 (2006) 491-501
7. Campos F., Duran R., Vidal L., Faro L.R., and Alfonso M. In vivo neurochemical characterization of anatoxin-a evoked dopamine release from striatum. J. Neural. Transm. 114 (2007) 173-184
8. Cao Y.J., Surowy C.S., and Puttfarcken P.S. Nicotinic acetylcholine receptor-mediated [3H]dopamine release from hippocampus. J. Pharmacol. Exp. Ther. 312 (2005) 1298-1304
9. Carmichael W.W., Biggs D.F., and Gorham P.R. Toxicology and pharmacological action of anabaena flos-aquae toxin. Science 187 (1975) 542-544
10. Chaurasia C.S. In vivo microdialysis sampling: theory and applications. Biomed. Chromatogr. 13 (1999) 317-332
11. Clarke P.B., and Reuben M. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release. Br. J. Pharmacol. 117 (1996) 595-606
12. Elmquist W.F., and Sawchuk R.J. Application of microdialysis in pharmacokinetic studies. Pharm. Res. 14 (1997) 267-288
13. Faro L.R., Do Nascimento J.L., Alfonso M., and Durán R. Mechanism of action of methylmercury on in vivo striatal dopamine release. Possible involvement of dopamine transporter. Neurochem. Int. 40 (2002) 455-465
14. Gago-Martinez, A., Rellan, S., Campos, F., Alfonso, M., Durán, R., 2003. HPLC determination of anatoxin-a. An application for the evaluation of this diffusion rate through the microdialysis probe. In: The 117th AOAC International Annual Meeting and Exposition, Atlanta.
15. Hansen D.K., Davies M.I., Lunte S.M., and Lunte C.E. Pharmacokinetic and metabolism studies using microdialysis sampling. Pharm. Sci. 88 (1999) 14-27
16. James K.J., Furey A., Sherlock I.R., Stack M.A., Twohig M., Caudwell F.B., and Skulberg O.M. Sensitive determination of anatoxin-a, homoanatoxin-a and their degradation products by liquid chromatography with fluorimetric detection. J. Chromatogr. A. 798 (1998) 147-157
17. Kehr J. A survey on quantitative microdialysis: theoretical models and practical implications. J. Neurosci. Methods. 48 (1998) 251-261
18. Macallan D.R., Lunt G.G., Wonnacott S., Swanson K.L., Rapoport H., and Albuquerque E.X. Methyllycaconitine and (+)-anatoxin-a differentiate between nAChRs in vertebrate and invertebrate nervous systems. FEBS Lett. 226 (1988) 357-363
19. 2+ ions in their function and desensitization. Neurochem. Int. 34 (1999) 319-328
20. Marshall D.L., Redfern P.H., and Wonnacott S. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J. Neurochem. 68 (1997) 1511-1519
21. Paxinos G., and Watson C. The rat brain. Stereotaxic Coordinates. fourth ed. (1986), Academic Press
22. Rellan S., Osswald J., Vasconcelos V., and Gago-Martinez A. Analysis of anatoxin-a in biological samples using liquid chromatography with fluorescence detection after solid phase extraction and solid phase microextraction. J. Chromatogr. A. 1156 (2007) 134-140
23. Sasongko L., Williams K.M., Ramzan I., and McLachlan A.J. Assessment of in vitro and in vivo recovery of gallamine using microdialysis. J. Pharmacol. Toxicol. Methods 44 (2000) 519-525
24. Sershen H., Balla A., Lajtha A., and Vizi E.S. Characterization of nAChRs involved in the release of noradrenaline from the hippocampus. Neuroscience 77 (1997) 121-130
25. Spivak C.E., Witkop B., and Albuquerque E.X. Anatoxin-a: a novel, potent agonist at the nicotinic receptor. Mol. Pharmacol. 18 (1980) 384-394
26. Swanson K.L., Allen C.N., Aronstam R.S., Rapoport H., and Albuquerque E.X. Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a. Mol. Pharmacol. 29 (1986) 250-257
27. Thomas P., Stephens M., Wilkie G., Amar M., Lunt G.G., Whiting P., Gallagher T., Pereira E., Alkondon M., Albuquerque E.X., and Wonnacott S. (+)-Anatoxin-a is a potent agonist at neuronal nicotinic acetylcholine receptors. J. Neurochem. 60 (1993) 2308-2311
28. Ungerstedt U. Microdialysis-principles and applications for studies in animals and man. J. Intern. Med. 230 (1991) 365-373
29. Wilkie G.I., Hutson P., Sullivan J.P., and Wonnacott S. Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes. Neurochem. Res. 21 (1996) 1141-1148
30. Zhou Q., and Gallo J.M. In vivo microdialysis for PK and PD studies of anticancer drugs. AAPS.J. 24 (2005) 659-667